Source link : https://www.newshealth.biz/health-news/early-intratracheal-budesonide-didnt-improve-outcomes-for-preterm-infants/
In extremely preterm infants receiving surfactant, early intratracheal budesonide had little to no effect on survival free of bronchopulmonary dysplasia (BPD), a randomized clinical trial found. Among 1,059 infants, survival without BPD occurred in 25.6% of infants who received budesonide and surfactant and 22.6% of infants who received only surfactant (adjusted risk difference 2.7%, 95% […]
Author : News Health
Publish date : 2024-11-11 22:39:16
Copyright for syndicated content belongs to the linked Source.